Chris Hamilton

Chris Hamilton has worked in global business development for 22 years and has been in the CRO sector since 2004. He joins Ixico from Labcorp Drug Development (formerly Covance) where he managed strategic accounts for top 10 pharma and also developed business in the biotech sector. Prior to this, he headed up the commercial divisions in CROs with approximately 100 – 180 employees. He has successfully developed business for companies across most therapeutic areas.